SITRAN at night lit up

Sheffield Institute for Translational Neuroscience

SITraN is an essential development in the fight against motor neurone disease, other common neurodegenerative disorders, stroke and neuroinflammatory conditions.

Photo of Queen Elizabeth II visiting SITraN in 2010
Photo of Queen Elizabeth II visiting SITraN in 2010
About SITraN 
Scientist taking notes in SITraN
Our impact 
SITraN facilities
Our research 
Neuroscience facilities
Study with us 
The exterior of the SITraN building at the University of Sheffield
Facilities 

News

L-R: Professor Sharrack and Professor Snowden at the therapeutic apheresis unit, where stem cells are collected, at Sheffield Teaching Hospitals NHS Foundation Trust

MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial

A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment.
Lumbar Puncture - treatment for MND
NIHR Sheffield Biomedical Research Centre

Promising MND drug helps slow disease progression and benefits patients physically

Scientists believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care, after the results of a Phase 3 clinical trial showed significant physical benefits for patients after 12 months.
Photo of the Golden Globe Race 2022 banner

Golden Globe Race 2022 - raising money for SITraN

And they’re off! On Sunday 4th September 23 skippers set sail on the prestigious Golden Globe Race. Fundraising for the University of Sheffield’s Institute for Translational Neuroscience, these skippers won’t return for at least 9 months!
Neurons Cells System - 3d rendered image of Interconnected Neurons with electrical pulses. Conceptual medical animation

Sheffield scientists benefit from £4.25 million to kick start MND research institute

Researchers from the University of Sheffield’s Institute for Translational Neuroscience (SITraN) have been awarded part of a new £4.25 million grant that seeks to discover meaningful MND treatments within years, not decades.